Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
ENVB on Nasdaq
Shares outstanding
2,083,186
Price per share
$0.61
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
363,849
Total reported value
$232,604
% of total 13F portfolios
0%
Share change
+129,691
Value change
+$42,617
Number of holders
11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTRACOASTAL CAPITAL, LLC 0.4% -92% $28,033 -$122,696 19,333 -81% Mitchell P. Kopin 18 Sep 2025

As of 30 Sep 2025, 11 institutional investors reported holding 363,849 shares of Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB). This represents 17% of the company’s total 2,083,186 outstanding shares.

Top 15 Institutional Shareholders

The largest institutional shareholders of Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB) together control 17% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
AdvisorShares Investments LLC 9.8% 203,679 +96% 0.02% $130,232
UBS Group AG 5.1% 105,333 +285% 0% $67,309
GEODE CAPITAL MANAGEMENT, LLC 1.4% 28,510 +1.2% 0% $18,229
CITADEL ADVISORS LLC 1.1% 22,674 0% $14,498
Tower Research Capital LLC (TRC) 0.12% 2,418 -18% 0% $1,546
BlackRock, Inc. 0.03% 601 0% 0% $384
SBI Securities Co., Ltd. 0.03% 600 0% 0% $384
BANK OF AMERICA CORP /DE/ 0% 26 +8.3% 0% $17
NATIONAL BANK OF CANADA /FI/ 0% 5 0% 0% $3
WELLS FARGO & COMPANY/MN 0% 2 0% 0% $1
GROUP ONE TRADING LLC 0% 1 0% 0% $1
Virtu Financial LLC 0% 0 -100% $0
RENAISSANCE TECHNOLOGIES LLC 0% 0 -100% $0
MORGAN STANLEY 0% 0 -100% $0
JONES FINANCIAL COMPANIES LLLP 0% 0 -100% $0

Institutional Holders of Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 363,849 $232,604 +$42,617 $0.64 11
2025 Q2 234,158 $283,214 -$34,110 $1.21 14
2025 Q1 253,209 $344,649 +$344,649 $1.39 14